FINWIRES · TerminalLIVE
FINWIRES

Climb Bio Sees Upgraded Outlook on Strong IgAN Drug Development Pipeline, Oppenheimer Says

-- Climb Bio (CLYM) is drawing increased analyst optimism following updated expectations for its immunology pipeline, particularly its investigational therapies for IgA nephropathy, Oppenheimer said in a Tuesday note.

Oppenheimer highlighted growing confidence in Climb Bio's anti-APRIL programs, including CLYM116, citing potential best-in-class efficacy, stronger-than-expected proteinuria reduction, longer dosing intervals, and a favorable safety profile as key differentiators.

According to the report, upcoming clinical readouts for subcutaneous budoprutug and CLYM116 could serve as key catalysts, potentially validating Climb Bio's IgAN approach, with strong pricing dynamics supporting commercial upside if results are positive.

Oppenheimer maintained its outperform rating on the stock and raised its price target to $18 from $10.

Shares of Climb Bio were up more than 6% in Tuesday trading.

Price: $9.49, Change: $+0.52, Percent Change: +5.80%

Related Articles

Equities

Feds Approve Enbridge's British Columbia Natural Gas Pipeline Expansion

The Federal government has approved Enbridge's (ENB.TO) $4 billion natural gas expansion of its Westcoast pipeline system in British Columbia, the company said on Friday.The Sunrise expansion program will add 300 million cubic feet per day of natural gas transportation capacity to the southern portion of the Westcoast pipeline system. Natural gas transported on the Westcoast system is used to heat homes, hospitals, businesses, and schools, and also supports electric power generation, industrial activity across B.C. and global LNG exports.The project will contribute more than $3 billion to Canada's economy, and will see 2,500 workers being hired during construction. More than $52 million has been spent on the hiring and procuring of services from Indigenous businesses, a statement added.Construction is scheduled to begin in July, with a targeted in-service date in late 2028."Leading up to and throughout construction, Enbridge will continue to work with Indigenous groups, local communities, contractors and other stakeholders. As part of our commitment to supporting local businesses, Enbridge is procuring pipe for the Sunrise Expansion Program from InterPro Pipe + Steel, a Canadian steel mill and pipe provider, who will use Canadian workers and expertise to produce the pipe." said Matthew Akman, Enbridge's executive vice president and president, gas transmission.Enbridge shares were last seen up US$0.09, to US$52.60, in New York trading.

$ENB.TO
Treasury

Advance Results For March Indicate Wholesale Sales (excluding petroleum, petroleum products, and other hydrocarbons and excluding oilseed and grain) Rose 1.3%, says StatsCan

$$CXY
Treasury

Brief: Canada's Retail Sales Rise 0.7% M/M in February; MUFG Says Consensus Saw 0.9% M/M Gain

$$CXY